Abstract

Preventive screening does not only allow to preemptively intervene on pathologies before they can harm the host; but also to reduce the costs of the intervention itself; boosting the efficiency of the NHS (National Health System) by saving resources for other purposes. To improve technology advancements in this field; user-friendly yet low-cost devices are required; and various applications for gas sensors have been tested and proved reliable in past studies. In this work; cell cultures and blood samples have been studied; using nanostructured chemoresistive sensors; to both verify if this technology can reliably detect tumor markers; and if correlations between responses from tumor line metabolites and the screening outcomes on human specimens could be observed. The results showed how sensors responded differently to the emanations from healthy and mutant (for cells) or tumor affected (for blood) samples, and how those results were consistent between them, since the tumoral specimens had higher responses compared to the ones of their healthy counterparts. Even though the patterns in the responses require a bigger population to be defined properly; it appeared that the different macro-groups between the same kind of samples are distinguishable from some of the sensors chosen in the study; giving promising outcomes for further research.

Highlights

  • The demand for reliable devices to detect tumor biomarkers in the human body is constantly increasing

  • These works rely on previous studies on Volatile Organic Compounds (VOCs) [8,9,10,11,12,13,14,15,16,17,18,19,20], a wide field that has opened the door to research on the application of electronic noses, biosensors, and chemoresistive sensors for medical purposes [21,22,23,24,25,26,27]

  • This means that it is possible to monitor the evolution of a mass of cells by studying how many metabolites they have produced over time, and monitor their vitality as well, as highlighted from results on Figure 2A,B

Read more

Summary

Introduction

The demand for reliable devices to detect tumor biomarkers in the human body is constantly increasing The reasons behind this lay on the advantages of early intervention on pathologies, allowing for a greater chance of healing and survival for the patients compared to taking action in the malignant state of a neoplasia not diagnosed in time. Sensors 2020, 20, 1411 this kind of approach, as multiple studies have proved their usefulness for screening applications on different biological samples [1,2,3,4,5,6,7] These works rely on previous studies on Volatile Organic Compounds (VOCs) [8,9,10,11,12,13,14,15,16,17,18,19,20], a wide field that has opened the door to research on the application of electronic noses, biosensors, and chemoresistive sensors for medical purposes [21,22,23,24,25,26,27]. The chemical markers targeted in this research have different origins, due to the various changes that tumor cell lines and masses undergo compared to their healthy counterpart:

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call